Article
  • Preparation of BCNU-loaded PLGA Wafers and In Vitro Release Behavior
  • Seong H, Moon DS, Khang G, Lee JS, Lee HB
  • BCNU 함유 PLGA 웨이퍼의 제조와 생체외 방출거동
  • 성하수, 문대식, 강길선, 이정식, 이해방
Abstract
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU, Carmustine)-loaded poly(D, L-lactide-co-glycolide) (PLGA, lactide/glycolide mole ratio 75：25) microparticles were prepared and fabricated into wafers in an attempt to study the possibility for the treatment of malignant glioma by direct inserting the wafers to the tumor or the cavity remained after surgical resection of the tumor. SEM observation of the microparticles prepared by spray drying method revealed that the microparticles were spherical, i. e. microspheres. Significant reduction of the crystallinity of BCNU encapsulated in PLGA was confirmed by X-ray diffraction and differential scanning calorimetry analyses of the BCNU-loaded PLGA microparticles. Release pattern of BCNU was dependent on several preparation parameters, such as the molecular weight and concentration of PLGA, and initial BCNU loading amount, etc. In vitro release of BCNU was prolonged over 8 weeks with close to zero-order release pattern after initial burst effect. Observations of morphological change of wafers and pH change of release media during release test period confirmed that hydration and degradation of PLGA would be facilitated with an increase of BCNU-loading amount.

종양부위 또는 종양을 수술로 제거한 부위에 직접 이식하여 항암제를 투여함으로써 종양 또는 종양재발을 억제하는 악성뇌종양치료에 이용하기 위한 국소서방성 항암제제로서 항암제1,3-bis(2- chloroethyl)-1-nitrosourea (BCNU, Carmustine)가 함유된 poly(D,L-lactide-co-glycolide) (PLGA, 락타이드와 글리콜라이드 몰비 75：25) 미분말을 제조하여 웨이퍼로 성형하였다. BCNU가 함유된 PLGA 미분말은 분사건조법에 의해 제조하였으며 주사전자현미경으로 관찰한 결과 제조된 미분말은 미립구의 형태를 나타내었다. XRD와 DSC를 통하여 PLGA에 포접된 BCNU의 결정성이 현저히 감소하였음을 확인하였다. 생체외 방출시험조건에서 BCNU의 방출경향은 PLGA의 분자량 및 농도, BCNU의 함량 등에 의존하였으며 초기 burst effect 이후 거의 0차 방출의 경향으로 8주 이상 지속적인 방출경향을 나타내었다. 방출시험기간 동안 웨이퍼의 형태변화를 관찰하고 방출시험액의 pH 변화를 측정함으로써 BCNU의 함량이 증가할수록 PLGA의 수화와 분해가 촉진됨을 확인하였다.

Keywords: brain tumor; BCNU; spray-drying; PLGA microparticles; wafers

References
  • 1. Black PM, N. Eng. J. Med., 324, 1471 (1991)
  •  
  • 2. Neuweit EA, Frenkel FP, Diehl J, Vu LH, Rapoport S, Hill S, Neurosurgery, 7, 44 (1980)
  •  
  • 3. Harbaugh RE, Sanders RL, Reeder RF, Neurosurgery, 23, 693 (1988)
  •  
  • 4. Penn RD, York MM, Paice JA, J. Neurosurg., 83, 215 (1995)
  •  
  • 5. Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA, Brain Res., 674, 171 (1995)
  •  
  • 6. Bickel U, Yoshikawa T, Pardridge WM, Adv. Drug. Deliv. Rev., 10, 205 (1993)
  •  
  • 7. Lindvall O, Bjorklund A, Acta Neurol. Scand., 126, 197 (1989)
  •  
  • 8. Gage FH, Wolff JA, Rosenberg MB, Xu L, Yee JK, Shults C, Friedmann T, Neuroscience, 23, 795 (1987)
  •  
  • 9. Tamargo RJ, Myseros JS, Epstein JI, Jang MB, Chasin M, Brem H, Cancer Res., 53, 329 (1993)
  •  
  • 10. Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H, Cancer Res., 54, 2207 (1994)
  •  
  • 11. Lillehei KO, Kong Q, Withrow SJ, KleinschmidtDeMasters B, Neurosurgery, 39, 1191 (1996)
  •  
  • 12. Minie P, Boisdron-Cller M, Croue A, Guy G, Benoit JP, Neurosurgery, 39, 117 (1996)
  •  
  • 13. Brem H, Mahaley MS, Vick NA, Black KL, Schold SC, Ellier TW, Cozzens JW, Kenealy JN, J. Neurosurg., 74, 441 (1991)
  •  
  • 14. Brem H, Ewend MG, Piantadosi S, Greehoot J, Burger PC, Sisti M, J. Neuo-oncol., 26, 111 (1995)
  •  
  • 15. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Schold R, Lancet., 345, 1008 (1995)
  •  
  • 16. Walter KA, Tarmargo RJ, Olivi A, Burger PC, Brem H, Neurosurgery, 37, 1129 (1995)
  •  
  • 17. Leong KW, D'Amore P, Marletta M, Langer R, J. Biomed. Mater. Res., 20, 51 (1986)
  •  
  • 18. Stephens D, Li L, Robinson D, Chen S, Chang H, Liu RM, Tian Y, Ginsburg EJ, Gao X, Stultz T, J. Control. Release, 63, 305 (2000)
  •  
  • 19. Akbari H, D'Emanuele A, Attwood D, Int. J. Pharm., 160, 83 (1998)
  •  
  • 20. Domb AJ, Israel ZH, Elmalak O, Teomim D, Bentolia A, Pharm. Res., 16(5), 762 (1999)
  •  
  • 21. Loo TL, Dion RL, Dixon RL, Rall DP, J. Pharm. Sci., 55(5), 492 (1966)
  •  
  • 22. Fredrikson K, Lundgren P, Acta Pharm. Suec., 23, 115 (1986)
  •  
  • 23. Painbeni T, Venier-Juliene MC, Benoit JP, Eur. J. Pharm. Biopharm., 45, 31 (1998)
  •  
  • 24. Cho JC, Khang G, Choi HS, Rhee JM, Lee HB, Polym.(Korea), 24(5), 728 (2000)
  •  
  • 25. Wakiyama N, Juni K, Nakano M, Chem. Pharm. Bull., 30(7), 2621 (1982)
  •  
  • 26. Kosima T, Nakano M, Juni K, Inoue S, Yoshida Y, Chem. Pharm. Bull., 32(7), 2795 (1994)
  •  
  • 27. Kelli M, Montheard JP, Vergnaud JM, Int. J. Pharm., 81, 103 (1992)
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 0379-153X(Print)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2023 Impact Factor : 0.4
  • Indexed in SCIE

This Article

  • 2002; 26(1): 128-138

    Published online Jan 25, 2002

  • Received on Aug 21, 2001
  • Accepted on Nov 12, 2001